These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
719 related items for PubMed ID: 14767338
21. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model]. Cao ZG, Liu JH, Zhou SW, Wu W, Yin CP, Wu JZ. Zhonghua Yi Xue Za Zhi; 2004 Aug 02; 84(15):1276-9. PubMed ID: 15387965 [Abstract] [Full Text] [Related]
22. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation? de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, Schröder FH. Scanning Microsc; 1995 Mar 02; 9(1):103-14. PubMed ID: 8553009 [Abstract] [Full Text] [Related]
23. Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria. Cao Y, Liu W, Hui L, Zhao J, Yang X, Wang Y, Niu H. Urolithiasis; 2016 Oct 02; 44(5):389-97. PubMed ID: 27040948 [Abstract] [Full Text] [Related]
24. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis. Tsujihata M, Miyake O, Yoshimura K, Kakimoto KI, Takahara S, Okuyama A. J Urol; 2000 Nov 02; 164(5):1718-23. PubMed ID: 11025758 [Abstract] [Full Text] [Related]
25. Role of sex hormones in experimental calcium oxalate nephrolithiasis. Fan J, Chandhoke PS, Grampsas SA. J Am Soc Nephrol; 1999 Nov 02; 10 Suppl 14():S376-80. PubMed ID: 10541267 [Abstract] [Full Text] [Related]
27. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation. de Bruijn WC, Boevé ER, van Run PR, van Miert PP, de Water R, Romijn JC, Verkoelen CF, Cao LC, van 't Noordende JM, Schrder FH. Scanning Microsc; 1995 Mar 02; 9(1):115-24; discussion 124-5. PubMed ID: 8553010 [Abstract] [Full Text] [Related]
28. Deposition of calcium phosphate and calcium oxalate crystals in the kidneys. Khan SR, Glenton PA. J Urol; 1995 Mar 02; 153(3 Pt 1):811-7. PubMed ID: 7861545 [Abstract] [Full Text] [Related]
29. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals. de Water R, Boevé ER, van Miert PP, Deng G, Cao LC, Stijnen T, de Bruijn WC, Schröder FH. Scanning Microsc; 1996 Mar 02; 10(2):591-601; discussion 601-3. PubMed ID: 9813634 [Abstract] [Full Text] [Related]
30. Effect of NADPH oxidase inhibition on the expression of kidney injury molecule and calcium oxalate crystal deposition in hydroxy-L-proline-induced hyperoxaluria in the male Sprague-Dawley rats. Zuo J, Khan A, Glenton PA, Khan SR. Nephrol Dial Transplant; 2011 Jun 02; 26(6):1785-96. PubMed ID: 21378157 [Abstract] [Full Text] [Related]
31. The trigger-maintenance model of persistent mild to moderate hyperoxaluria induces oxalate accumulation in non-renal tissues. Marengo SR, Zeise BS, Wilson CG, MacLennan GT, Romani AM. Urolithiasis; 2013 Nov 02; 41(6):455-66. PubMed ID: 23821183 [Abstract] [Full Text] [Related]
32. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis. Meimaridou E, Lobos E, Hothersall JS. Am J Physiol Renal Physiol; 2006 Oct 02; 291(4):F731-40. PubMed ID: 16670437 [Abstract] [Full Text] [Related]
33. Shock wave induced kidney injury promotes calcium oxalate deposition. Xue YQ, He DL, Chen XF, Li X, Zeng J, Wang XY. J Urol; 2009 Aug 02; 182(2):762-5. PubMed ID: 19539311 [Abstract] [Full Text] [Related]
34. The urinary response to an oral oxalate load in recurrent calcium stone formers. Krishnamurthy MS, Hruska KA, Chandhoke PS. J Urol; 2003 Jun 02; 169(6):2030-3. PubMed ID: 12771711 [Abstract] [Full Text] [Related]
35. Renal prothrombin mRNA is significantly decreased in a hyperoxaluric rat model of nephrolithiasis. Grover PK, Miyazawa K, Coleman M, Stahl J, Ryall RL. J Pathol; 2006 Nov 02; 210(3):273-81. PubMed ID: 16981243 [Abstract] [Full Text] [Related]
36. Hepatocyte growth factor has protective effects on crystal-cell interaction and crystal deposits. Tei N, Tsujihata M, Tsujikawa K, Yoshimura K, Nonomura N, Okuyama A. Urology; 2006 Apr 02; 67(4):864-9. PubMed ID: 16600342 [Abstract] [Full Text] [Related]
37. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity. Corley RA, Wilson DM, Hard GC, Stebbins KE, Bartels MJ, Soelberg JJ, Dryzga MD, Gingell R, McMartin KE, Snellings WM. Toxicol Appl Pharmacol; 2008 Apr 15; 228(2):165-78. PubMed ID: 18191429 [Abstract] [Full Text] [Related]
38. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. Sidhu H, Schmidt ME, Cornelius JG, Thamilselvan S, Khan SR, Hesse A, Peck AB. J Am Soc Nephrol; 1999 Nov 15; 10 Suppl 14():S334-40. PubMed ID: 10541258 [Abstract] [Full Text] [Related]
39. Unusual morphology of calcium oxalate calculi in primary hyperoxaluria. Daudon M, Estepa L, Lacour B, Jungers P. J Nephrol; 1998 Nov 15; 11 Suppl 1():51-5. PubMed ID: 9604812 [Abstract] [Full Text] [Related]
40. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits? Osther PJ. Scand J Urol Nephrol; 1999 Dec 15; 33(6):368-71. PubMed ID: 10636575 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]